OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2026)
OptimizeRx's Non-Current Deferred Tax Liability history spans 8 years, with the latest figure at $10.8 million for Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 139.5% to $10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.8 million, a 139.5% increase, with the full-year FY2025 number at $10.8 million, up 139.5% from a year prior.
- Non-Current Deferred Tax Liability hit $10.8 million in Q4 2025 for OptimizeRx, up from $4.5 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for OPRX hit a ceiling of $10.8 million in Q4 2025 and a floor of $2.3 million in Q4 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $4.3 million across 5 years, with a median of $4.3 million in 2023.
- The widest YoY moves for Non-Current Deferred Tax Liability: up 139.5% in 2025, down 20.27% in 2025.
- Tracing OPRX's Non-Current Deferred Tax Liability over 5 years: stood at $2.6 million in 2021, then dropped by 11.07% to $2.3 million in 2022, then surged by 86.14% to $4.3 million in 2023, then grew by 3.55% to $4.5 million in 2024, then surged by 139.5% to $10.8 million in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for OPRX at $10.8 million in Q4 2025, $4.5 million in Q3 2025, and $3.5 million in Q2 2025.